Literature DB >> 12920609

Identification of 46 novel SNPs in the 130-kb region containing a myocardial infarction susceptibility gene on chromosomal band 6p21.

Aritoshi Iida1, Kouichi Ozaki2, Yozo Ohnishi2, Toshihiro Tanaka2, Yusuke Nakamura3,4.   

Abstract

We identified a total of 187 single-nucleotide polymorphisms (SNPs) at 11 gene loci in the 130-kb region on chromosome 6p21 containing a gene strongly associated with myocardial infarction (MI). By comparing our data with SNPs deposited in the dbSNP database at the National Center for Biotechnology Information, 46 of these SNPs (24.6%) were considered to be novel: four were identified in the P5-1 locus, 14 in the MICB locus, nine in the BAT1 locus, one in the ATP6V1G2 locus, six in the NFKBIL1 locus, one in the LTA locus, one in the TNF locus, five in the LST1 locus, four in the LY117a locus, and one in the AIF-1 locus. The SNP map presented here should provide as useful resource not only for examining the relationships between genotypes and susceptibility to the MI phenotype, but also for scanning of complex diseases mapped to this local segment on chromosome 6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920609     DOI: 10.1007/s10038-003-0054-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  5 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  Catalog of 668 SNPs detected among 31 genes encoding potential drug targets on the cell surface.

Authors:  Aritoshi Iida; Susumu Saito; Akihiro Sekine; Chihiro Mishima; Yuri Kitamura; Kimie Kondo; Satoko Harigae; Saori Osawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003       Impact factor: 3.172

3.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

4.  Cardiovascular disease burden increases, NIH funding decreases.

Authors:  J L Breslow
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

5.  Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction.

Authors:  Kouichi Ozaki; Yozo Ohnishi; Aritoshi Iida; Akihiko Sekine; Ryo Yamada; Tatsuhiko Tsunoda; Hiroshi Sato; Hideyuki Sato; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

  5 in total
  5 in total

Review 1.  Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis.

Authors:  Yan Liu; Wenquan Niu; Zhijun Wu; Xiuxiu Su; Qiujin Chen; Lin Lu; Wei Jin
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 2.  V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.

Authors:  Xiaohong Duan; Shaoqing Yang; Lei Zhang; Tielin Yang
Journal:  Theranostics       Date:  2018-10-26       Impact factor: 11.556

3.  Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy.

Authors:  Chunguang Guo; Zaoqu Liu; Can Cao; Youyang Zheng; Taoyuan Lu; Yin Yu; Libo Wang; Long Liu; Shirui Liu; Zhaohui Hua; Xinwei Han; Zhen Li
Journal:  Front Cell Dev Biol       Date:  2022-03-17

4.  CASP1 Gene Polymorphisms and BAT1-NFKBIL-LTA-CASP1 Gene-Gene Interactions Are Associated with Restenosis after Coronary Stenting.

Authors:  Gilberto Vargas-Alarcón; Julian Ramírez-Bello; Marco Antonio Peña-Duque; Marco Antonio Martínez-Ríos; Hilda Delgadillo-Rodríguez; José Manuel Fragoso
Journal:  Biomolecules       Date:  2022-05-31

Review 5.  Association of A561C and G98T polymorphisms in E-selectin gene with coronary artery disease: a meta-analysis.

Authors:  Xiaoyan Wang; Junxiao Zhang; Xunbo Du; Minmin Song; Chongqi Jia; Huanliang Liu
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.